Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Gynecologic 1Breast 1

Conditions

Drug-Related Side Effects and Adverse Reactions 19Head and Neck Neoplasms 15Lung Neoplasms 12Radiation Injuries 11Ovarian Neoplasms 10Leukemia 9Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Ovarian Epithelial 8Carcinoma, Non-Small-Cell Lung 8Leukemia, Myeloid, Acute 7Sarcoma 6Lymphoma, Non-Hodgkin 6Lymphoma 6Hodgkin Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Breast Neoplasms 5Neurotoxicity Syndromes 4Multiple Myeloma 4Xerostomia 3Waldenstrom Macroglobulinemia 3Uterine Cervical Neoplasms 3Testicular Neoplasms 3

Interventions

Docetaxel 277Prednisone 237enzalutamide 177Leuprolide 172Radiotherapy 164Abiraterone Acetate 154Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 79abiraterone 77gallium 68 PSMA-11 74Specimen Handling 67darolutamide 58Gonadotropin-Releasing Hormone 58Radiation 56Triptorelin Pamoate 53cabazitaxel 50Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Amifostine × Clear all
NCT00078845 2012-10-17

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
24 enrolled
BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Neurotoxicity Syndromes, Small Cell Lung Carcinoma

NCT00040365 2012-04-30

Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
30 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00003307 2010-03-16

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

University of Arizona

Phase 2 Completed
25 enrolled
Genitourinary

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡